PMC:7784786 / 15631-15707 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"543","span":{"begin":9,"end":17},"obj":"Species"},{"id":"546","span":{"begin":33,"end":43},"obj":"Chemical"}],"attributes":[{"id":"A543","pred":"tao:has_database_id","subj":"543","obj":"Tax:9606"},{"id":"A546","pred":"tao:has_database_id","subj":"546","obj":"MESH:C000597346"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" initial patients. The impact of itolizumab on circulating T cells are being"}